More tools

EDAP TMS S.A.

EDAP

EDAP TMS S.A.

1.96

0.03

(1.28%)

Today

As of 4:00 PM Eastern

After Hours:

1.96

0.00

Options AI - All Directions

Apr 17 Expected Move

See where the options market thinks EDAP will move from here.

Market Closed

2025-03-03 09:00:002025-03-13 12:30:002025-03-25 16:00:002025-04-07 11:30:002025-04-17 15:00:00$2.61$1.31

News

EDAP TMS S.A. (EDAP) Q4 2024 Earnings Call Transcript

EDAP TMS S.A. (NASDAQ:EDAP ) Q4 2024 Earnings Conference Call March 27, 2025 8:30 AM ET Company Participants John Fraunces - IR, LifeSci Advisors Ryan Rhodes - CEO Ken Mobeck - CFO Conference Call Participants Michael Sarcone - Jefferies Swayampakula Ramakanth - H.C.

seekingalpha.com • Mar 27, 2025 11:56 Eastern
EDAP TMS S.A. (EDAP) Q4 2024 Earnings Call Transcript
EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results

Record full-year 2024 HIFU revenue of USD 25.7 million, an increase of 15.3% over full-year 2023 Record Q4 2024 HIFU revenue of USD 9.3 million, an increase of 15.0% over Q4 2023 U.S. Focal One HIFU procedures grew 51% on a year-over-year basis in 2024 Focal One receives CE Mark for the treatment of deep infiltrating endometriosis Recent landmark HIFI study publication demonstrates positive outcomes with Focal One® Robotic HIFU versus surgery in the management of prostate cancer First patients treated in Phase I/II study evaluating Focal One Robotic HIFU for the treatment of Benign Prostatic Hyperplasia (BPH) Company to host conference call and webcast today, March 27th, at 8:30 a.m. EDT AUSTIN, Texas, March 27, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, reported today unaudited consolidated financial results for the fourth quarter and full-year 2024.

globenewswire.com • Mar 27, 2025 07:10 Eastern
EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results
EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Company to host conference call and webcast on Thursday, March 27 th at 8:30am EDT AUSTIN, Texas, March 6, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2024, before the markets open on Thursday, March 27th, 2025. An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer.

globenewswire.com • Mar 06, 2025 07:00 Eastern
EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
EDAP Appoints Glen French to Board of Directors

PDF Version LYON, France, March 3, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Glen French to its Board of Directors.          “We are pleased to welcome Glen to our Board of Directors," said Dr. Lance Willsey, Interim Chairman of the Board of EDAP TMS.

globenewswire.com • Mar 03, 2025 07:00 Eastern
EDAP Appoints Glen French to Board of Directors
Cortechs.ai and EDAP Announce World's First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center

San Diego, CA and Austin, Texas, February 6, 2025 - Cortechs.ai, an emerging leader in novel imaging solutions for prostate cancer care, and EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced the successful completion of the world's first OnQ Prostate-assisted Focal One® Robotic HIFU procedure at the University of California, San Francisco (UCSF) Prostate Center. This milestone marks the first clinical application of OnQ Prostate's patented RSI technology to guide focal therapy, demonstrating how advanced MR-imaging can improve lesion localization and targeting for urologists performing focal therapy.

globenewswire.com • Feb 06, 2025 08:00 Eastern
Cortechs.ai and EDAP Announce World's First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center
EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures

Company Reports Preliminary Worldwide Record Fourth Quarter Sales of 11 Focal One Systems  Record U.S. Fourth Quarter Focal One System Sales Record Number of U.S. Focal One Procedures, with Year-Over-Year Growth of 30% PDF Version AUSTIN, Texas, January 13, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced preliminary record Focal One System sales for the fourth quarter of calendar year 2024. The Company experienced robust demand for its Focal One Robotic HIFU technology, reporting preliminary record fourth quarter of 11 Focal One Systems.

globenewswire.com • Jan 13, 2025 07:00 Eastern
EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures
EDAP Appoints Joshua H. Levine to Board of Directors

PDF Version

globenewswire.com • Jan 10, 2025 07:00 Eastern
EDAP Appoints Joshua H. Levine to Board of Directors
EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology

AUSTIN, Texas, January 8, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored by the Centre Léon Bérard, Lyon, France, evaluating proprietary High Intensity Focused Ultrasound (HIFU) technology for the treatment of pancreatic tumors.

globenewswire.com • Jan 08, 2025 07:00 Eastern
EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology